NIHの資金調達:未来はどうなるのか?

Same author

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

Journal of Parkinson's disease·2024

Same author

The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.

Science translational medicine·2023

Same author

Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity.

Movement disorders : official journal of the Movement Disorder Society·2021

Same author

Seeking progress in disease modification in Parkinson disease.

Parkinsonism & related disorders·2021

Same author

Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.

Neurobiology of disease·2020

Same author

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

BMC pharmacology & toxicology·2018

Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026

Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026

Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026

Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026

Same journal

Retraction.

Science (New York, N.Y.)·2026

Same journal

Making time.

Science (New York, N.Y.)·2026

関連する実験動画

NIHの資金調達:未来はどうなるのか?

関連する概念動画

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.

Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity.

Seeking progress in disease modification in Parkinson disease.

Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Local signals, systemic decline.

The mechanics of liver regeneration.

Computing in a memory with physics.

Retraction.

Making time.

関連する実験動画

NIHの資金調達:未来はどうなるのか?

関連する概念動画

関連記事

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.

Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity.

Seeking progress in disease modification in Parkinson disease.

Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Local signals, systemic decline.

The mechanics of liver regeneration.

Computing in a memory with physics.

Retraction.

Making time.